SMMT

NASDAQSummit Therapeutics PLC
High Tide · 71Squeeze · Watch 41Neutral0 buys · $0Social · No data 0
$17.28
$-0.32 (-1.85%)
15-min delayed · Sep 8, 5:23 PMReal-time

Score summary

Buy
Analyst Ratings
13Ratings
6 Buy7 Hold0 Sell
Tide Score
71
High Tide · stable · Top 9% of universe (3990)
Outlook74High Tide · stable · Top 8% of universe (3991)
Squeeze Score
41
Watch ·
  • Days to cover8.69
  • Short interest21.65% of float
  • Borrow rate42.97%
  • Short interest trend+0.15% (30d)
Trend
Neutral
No clear trend (signals split)
Recent Smart Money
0 buys
Quiet · $0 · 14d · 4 super investors

Key statistics

Market Cap
$14.04B
52-week range
$12.43 – $26.38
42% from low
Day range
$17 – $18
Open $16.93
Volume
6.9M
vs 5.5M avg · 125%
P/E (TTM)
25.0
Fwd —
Earnings
Oct 19
41d · est $-0.21

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 13 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$23
13 Wall St 12-month targets
High
$40
Average
$27
Low
$12
$11$18$26$34$41HIGH$40MEDIAN$23LOW$11.9Mar ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 62/100 Analyst Score (Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Oct 19 (post-market, est EPS $-0.21) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.